$22.30
N/A
Last update: Nov 9, 4:00 PM
Tyra Biosciences Inc
TYRANASDAQ
The average analyst price target for Tyra Biosciences is $43.87, 96.7% above the current price. Of 13 analysts, 13 rate it Buy. Targets range from $28 to $59. The latest change came on Sep 22, 2026, when Oppenheimer lowered its price target on Tyra Biosciences from $50 to $40 and kept an Outperform rating.
Price Target Range — 12 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
